Cynomolgus gp80 receptor and uses thereof

Details Cynomolgus gp80 receptor and uses thereof Cynomolgus gp80 receptor and uses thereof

2011-04-26

2011-04-26

Landsman, Robert (Department: 1646)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C530S350000, C424S139100, C424S143100, C424S198100

Reexamination Certificate

active

07931905

ABSTRACT:
Isolated polynucleotides encoding cynomolgus monkey gp80, polypeptides obtainable from expression of these polynucleotides, compositions, recombinant cells, methods of making and using these polynucleotides, polypeptides, and compositions are useful in development of human therapeutics.

REFERENCES:
patent: 5807715 (1998-09-01), Morrison et al.
Yamasaki et al., “Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor,” Science 241: 825-828 (1988).
Novick, et al., “Soluble Cytokine Receptors Are Present in Normal Human Urine,” Journal of Experimental Medicine, 170: 1409-1414 (1989).
Yasukawa et al., “Purification and Characterization of Soluble Human IL-6 Receptor Expressed in CHO Cells,” Journal of Biochemistry, 108: 673-676 (1990).
Kohler et al., “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, 256: 495-497 (1975).
Queen, et al., “A humanized antibody that binds to the interleukin 2 receptor,” Proceedings of the National Academy of Science, USA, 86: 10029-10033 (1989).
Hodgson, et al., “Making Monoclonals in Microbes,” Bio/Technology, 9: 421-421 (1991).
Lonberg, et al., “Antigen-specific human antibodies from mice comprising four distinct genetic modifications,” Nature, 368: 856-859 (1994).
Knappik, et al., “Fully Synthetic Human Combinatorial Antibody Libraries (HuCAL) Based on Modular Consensus Frameworks and CDRs Randomized with Trinucleotides,” Journal of Molecular Biology, 296: 57-86 (2000).
Mendez, et al., “Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice,” Nature Genetics, 15: 146-156 (1997).
Krebs, et al, “High-throughput generation and engineering of recombinant human antibodies,” Journal of Immunological Methods, 254: 67-84 (2001).
Fishwild, et al., “High avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice,” Nature Biotechnology 14, 845-851 (1996).
Gentz et al., “Bioassay for trans-activation using purified human immunodeficiency virustat-encoded protein: Trans-activation requires mRNA synthesis,” Proceedings of the National Academy of Science USA, 86: 821-824 (1989).
Genbank Accession No. XM 001114404, Jun. 14, 2006.

Affiliated with

Also associated with

Rating

Cynomolgus gp80 receptor and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cynomolgus gp80 receptor and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cynomolgus gp80 receptor and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2671631